PortfoliosLab logoPortfoliosLab logo
DTIL vs. TGTX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

DTIL vs. TGTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Precision BioSciences, Inc. (DTIL) and TG Therapeutics, Inc. (TGTX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, DTIL achieves a 45.19% return, which is significantly higher than TGTX's 34.55% return.


DTIL

1D
-4.43%
1M
-20.84%
YTD
45.19%
6M
19.37%
1Y
17.28%
3Y*
-35.49%
5Y*
-55.07%
10Y*

TGTX

1D
9.47%
1M
12.34%
YTD
34.55%
6M
26.89%
1Y
10.16%
3Y*
14.73%
5Y*
2.66%
10Y*
17.63%
*Multi-year figures are annualized to reflect compound growth (CAGR)

DTIL vs. TGTX - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
DTIL
Precision BioSciences, Inc.
45.19%9.19%-65.21%-69.33%-83.92%-11.27%-39.96%-20.36%
TGTX
TG Therapeutics, Inc.
34.55%-0.96%76.23%44.38%-37.74%-63.48%368.65%48.79%

Correlation

The correlation between DTIL and TGTX is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.25

Correlation (3Y)
Calculated over the trailing 3-year period

0.22

Correlation (5Y)
Calculated over the trailing 5-year period

0.36

Correlation (All Time)
Calculated using the full available price history since Mar 29, 2019

0.35

The correlation between DTIL and TGTX shifts across timeframes, from 0.22 (3 years) to 0.36 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

DTIL:

$148.79M

TGTX:

$6.42B

EPS

DTIL:

-$2.95

TGTX:

$2.87

PS Ratio

DTIL:

2.02

TGTX:

9.21

PB Ratio

DTIL:

1.96

TGTX:

11.01

Total Revenue (TTM)

DTIL:

$45.07M

TGTX:

$700.35M

Gross Profit (TTM)

DTIL:

$32.19M

TGTX:

$581.54M

EBITDA (TTM)

DTIL:

-$30.02M

TGTX:

$156.88M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

DTIL vs. TGTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DTIL
DTIL Risk / Return Rank: 4949
Overall Rank
DTIL Sharpe Ratio Rank: 5050
Sharpe Ratio Rank
DTIL Sortino Ratio Rank: 5151
Sortino Ratio Rank
DTIL Omega Ratio Rank: 4848
Omega Ratio Rank
DTIL Calmar Ratio Rank: 4848
Calmar Ratio Rank
DTIL Martin Ratio Rank: 4747
Martin Ratio Rank

TGTX
TGTX Risk / Return Rank: 4646
Overall Rank
TGTX Sharpe Ratio Rank: 4848
Sharpe Ratio Rank
TGTX Sortino Ratio Rank: 4545
Sortino Ratio Rank
TGTX Omega Ratio Rank: 4545
Omega Ratio Rank
TGTX Calmar Ratio Rank: 4747
Calmar Ratio Rank
TGTX Martin Ratio Rank: 4646
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DTIL vs. TGTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Precision BioSciences, Inc. (DTIL) and TG Therapeutics, Inc. (TGTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


DTILTGTXDifference
Sharpe ratioReturn per unit of total volatility

+0.03

Sortino ratioReturn per unit of downside risk

+0.18

Omega ratioGain probability vs. loss probability

1.10

1.08

+0.02

Calmar ratioReturn relative to maximum drawdown

0.30

0.30

0.00

Martin ratioReturn relative to average drawdown

0.56

0.52

+0.04

DTIL vs. TGTX - Sharpe Ratio Comparison

The current DTIL Sharpe Ratio is 0.25, which is comparable to the TGTX Sharpe Ratio of 0.22. The chart below compares the historical Sharpe Ratios of DTIL and TGTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


DTILTGTXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.25

0.22

+0.03

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.70

0.03

-0.73

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.20

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.55

-0.05

-0.50

Drawdowns

DTIL vs. TGTX - Drawdown Comparison

The maximum DTIL drawdown since its inception was -99.39%, roughly equal to the maximum TGTX drawdown of -99.52%. Use the drawdown chart below to compare losses from any high point for DTIL and TGTX.


Loading charts...

Drawdown Indicators


DTILTGTXDifference

Max Drawdown

Largest peak-to-trough decline

-99.39%

-99.52%

+0.13%

Max Drawdown (1Y)

Largest decline over 1 year

-58.54%

-34.12%

-24.42%

Max Drawdown (3Y)

Largest decline over 3 years

-85.40%

-76.95%

-8.45%

Max Drawdown (5Y)

Largest decline over 5 years

-99.16%

-90.75%

-8.41%

Max Drawdown (10Y)

Largest decline over 10 years

-93.19%

Current Drawdown

Current decline from peak

-98.98%

-82.82%

-16.16%

Average Drawdown

Average peak-to-trough decline

-77.65%

-91.47%

+13.82%

Ulcer Index

Depth and duration of drawdowns from previous peaks

30.78%

19.60%

+11.18%

Volatility

DTIL vs. TGTX - Volatility Comparison

Precision BioSciences, Inc. (DTIL) has a higher volatility of 20.95% compared to TG Therapeutics, Inc. (TGTX) at 19.58%. This indicates that DTIL's price experiences larger fluctuations and is considered to be riskier than TGTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


DTILTGTXDifference

Volatility (1M)

Calculated over the trailing 1-month period

20.95%

19.58%

+1.37%

Volatility (6M)

Calculated over the trailing 6-month period

49.88%

33.27%

+16.61%

Volatility (1Y)

Calculated over the trailing 1-year period

68.81%

46.62%

+22.19%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

79.38%

87.72%

-8.34%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

84.87%

86.87%

-2.00%

Dividends

DTIL vs. TGTX - Dividend Comparison

Neither DTIL nor TGTX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

DTIL vs. TGTX - Financials Comparison

This section allows you to compare key financial metrics between Precision BioSciences, Inc. and TG Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M20222023202420252026
10.84M
204.92M
(DTIL) Total Revenue
(TGTX) Total Revenue
Values in USD except per share items

Frequently Asked Questions


DTIL and TGTX have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

DTIL has higher volatility (20.95%) compared to TGTX (19.58%). In terms of maximum drawdown, DTIL dropped -99.39% vs TGTX's -99.52%.

DTIL currently has the higher Sharpe Ratio (0.25 vs 0.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for DTIL and TGTX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer